Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/9031
Title: Treatment of trochanteric bursitis: Our experience
Authors: Nurkovic J.
Jovasevic Lj.
Konicanin A.
Bajin Z.
Parezanovic Ilic, Katarina
Grbovic, Vesna
Jurisic Skevin, Aleksandra
Dolicanin Z.
Issue Date: 2016
Abstract: © 2016 The Society of Physical Therapy Science. [Purpose] Trochanteric bursitis is a disease for which there are no effective standardized therapy protocols. Very often pain persists in spite of applying all therapeutic treatments. The purpose of this study was to determine whether treatment of trochanteric bursitis with a local injection of bicomponent corticosteroid and 2% lidocaine would improve patients’ conditions and relieve pain symptoms in the trochanteric area. [Subjects and Methods] A retrospective observational study was conducted of 2,217 patients in a 6 year follow-up period at the Special Hospital “Agens”, Mataruska Banja, Serbia. [Results] Of 2,217 examined patients, 58 (2.6%) patients were found to suffer from trochanteritis associated with low back pain, and 157 (7%) were found to suffer from trochanteric pains without low back pains. Local corticosteroid therapy followed by physical therapy was effective in 77 (49%) of these patients, and only corticosteroid injection in 61 (39%) patients. A single injection was given to 47 (29.9%) of the patients. Two injections were given to 9 (5.7%) patients, and from 3 to 5 injections were given repeatedly every 4–6 weeks to 7 (4.5%) patients. [Conclusion] For most patients, local injections of corticosteroids with lidocaine alone or followed by physical therapy gave satisfactory results.
URI: https://scidar.kg.ac.rs/handle/123456789/9031
Type: article
DOI: 10.1589/jpts.28.2078
ISSN: 0915-5287
SCOPUS: 2-s2.0-84979738372
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

130

Downloads(s)

25

Files in This Item:
File Description SizeFormat 
10.1589-jpts.28.2078.pdf540.05 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons